Dishman Carbogen Amcis Ltd is engaged in Contract Research and Manufacturing Services (CRAMS) and manufacture and supply of marketable molecules such as specialty chemicals, vitamins & chemicals and disinfectants with presence in Switzerland, UK, Europe, China and other countries.
Financial Results:
Dishman Carbogen Amcis Ltd reported Revenues for Q1FY24 of ₹723.00 Crores up from ₹541.00 Crore year on year, a rise of 33.64%.
Total Expenses for Q1FY24 of ₹700.00 Crores up from ₹546.00 Crores year on year, a rise of 28.21%.
Consolidated Net Profit of ₹17.00 Crores up 325.0% from ₹4.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹1.08, up 315.38% from ₹0.26 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.